PFSA stock news · Profusa
Get alerts for PFSA
Follow Profusa (PFSA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PFSA12 health care stocks are changing a lot before the market opens on Thursday.
NeutralProfusa shares rose about 15%, but the article gives no company news explaining the move. It does not change the company's outlook.
On Thursday, 12 health care stocks saw big price changes, with Regencell Bioscience jumping up 30.4%.
NeutralProfusa shares fell 20% in Thursday's session, but the article gives no company update. This trading report does not change the outlook for Profusa's business.
12 health care stocks are changing a lot before the market opens on Thursday.
NeutralProfusa shares fell in pre-market trading. The roundup gives no company update explaining the fall, so it does not change the business outlook.
Profusa, Inc. has signed an important agreement and will issue a note worth about $769,230.77.
Bad for PFSAProfusa received $700,000 through a secured loan, but owes $769,000 in principal and must make monthly payments. The repayment burden and possible share issuance weigh against the company.
12 health care companies are changing prices before the market opens on Wednesday.
NeutralThe report says PFSA shares fell 10.14%, but gives no company news or reason for the drop. That alone does not show a change in its business outlook.
Here are 12 health care stocks that changed a lot during Friday's trading.
NeutralProfusa shares fell 24.76% during Friday's session, but the article gives no company news or reason for the drop. It does not change the outlook for Profusa.
On Thursday, 12 health care stocks changed a lot during the day.
NeutralProfusa shares rose to $2.76 intraday, but the piece contains no new company disclosure, so it does not alter how we read the company.
12 health care companies are changing prices before the market opens on Wednesday.
NeutralProfusa stock declined 16.13% pre-market to $1.82, but there is no company-specific news in the report to change how we read the firm.
After-hours trading sees Profusa's shares fall 35.04% as a massive 506% increase stabilizes: Here's the reason PFSA is in the spotlight.
Bad for PFSAProfusa Inc. experienced a dramatic 35.04% decline in after-hours trading following a 506% surge earlier in the day. This volatility is linked to the company's announcement of a special meeting to vote on a reverse stock split aimed at regaining compliance with Nasdaq's minimum bid price requirement.
Today, investors are focusing on five stocks: Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast, and Klarna Group.
NeutralProfusa's dramatic stock surge due to a reverse stock split has drawn significant investor attention, while Baidu's disappointing earnings report has led to a notable decline in its share price. Amylyx Pharmaceuticals also saw a substantial increase following positive data, contributing to a mixed but overall positive sentiment in the market.